The cash conversion cycle of the company is 345 days (although it is decreasing YoY but it is still high compared to other pharma companies that I skimmed through). At the same time its CFO has increased to over 1200 crores (roughly 50% more than last year). I am a bit confused about the company because of the aforesaid. Would you be having a logical explanation behind this? With such a high number for the working capital days, how are the cash flows increasing?
Subscribe To Our Free Newsletter |